HISTORY

Cannatiba was founded in 2022 to provide high quality raw materials, and APIS, to the pharmaceutical industry. To obtain the necessary knowledge, resources and approvals, a highly experienced multidisciplinary team was formed and committed to improving the quality of social health through cannabis.

Over the last few years, Cannatiba has developed this project based on cannabis cultivation behaviour, scientific evidence, market development and collaboration with the Spanish authorities.

Currently, we have applied to be authorised by the AEMPS (Spanish Medicines Agency) to produce the first batches for the validation of the manufacturing process of active pharmaceutical ingredients (APS's) for medical purposes.

VISION

Our VISION is to be a reference in the medical cannabis market, through a strong commitment to people's health and quality of life, as well as to the quality and innovation of our product.

MISSION

Our MISSION is to facilitate user access to safe and effective cannabinoid-based products. To this end, Cannatiba is involved in the sustainable and organic cultivation of this product and in collaboration with the pharmaceutical industry for its development and marketing at an international level, especially in the USA and Canada, in the pharmaceutical and cosmetics industries.

Company

HISTORY

VISION

MISSION

Medical Cannabis

Cultivating Health